Paroxysmal Nocturnal Hemoglobinuria  >>  Soliris (eculizumab)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Soliris (eculizumab) / AstraZeneca
ACTRN12619000694112: A randomised, double-blind, single-dose study to evaluate the pharmacokinetic, safety, tolerability, immunogenicity and pharmacodynamic profile of ISU305 compared to Soliris® (Eculizumab) in Healthy Male Volunteers

Completed
1
148
 
ISU Abxis, ISU Abxis
Paroxysmal nocturnal haemoglobinuria (PNH) , Atypical haemolytic uraemic syndrome (aHUS)
 
 

Download Options